.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Johnson and Johnson
Moodys
US Army
Fuji
Citi
Baxter
Chubb
Chinese Patent Office

Generated: September 24, 2017

DrugPatentWatch Database Preview

PHENAZINE Drug Profile

« Back to Dashboard

What is the patent landscape for Phenazine, and what generic Phenazine alternatives are available?

Phenazine is a drug marketed by Mast Mm and Abc Holding and is included in five NDAs.

The generic ingredient in PHENAZINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

Summary for Tradename: PHENAZINE

Patents:0
Applicants:2
NDAs:5
Bulk Api Vendors: see list58
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PHENAZINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mast Mm
PHENAZINE
phendimetrazine tartrate
TABLET;ORAL087305-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mast Mm
PHENAZINE
phendimetrazine tartrate
CAPSULE;ORAL086525-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mast Mm
PHENAZINE
phendimetrazine tartrate
CAPSULE;ORAL086523-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mast Mm
PHENAZINE
phendimetrazine tartrate
CAPSULE;ORAL086524-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abc Holding
PHENAZINE-35
phendimetrazine tartrate
TABLET;ORAL085512-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Moodys
Merck
Deloitte
Harvard Business School
Mallinckrodt
Daiichi Sankyo
Baxter
McKesson
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot